Confirmation of the diagnosis can be accomplished through the discovery of Entamoeba histolytica antigen or DNA in the patient's feces, or antibodies against the parasite in the blood serum.
The treatment consists of nitroimidazoles, such as metronidazole or tinidazole, and then luminal medicines, such as paromomycin or diloxanide furoate, are administered to prevent relapse after the initial treatment. In areas where the disease is prevalent, reinfection is common; patients should be counselled on ways to lower their chances of contracting the disease again.
The trophozoites of Entamoeba histolytica that are present in the intestines and tissue are eliminated by metronidazole, while the cysts that are present in the intestines remain. It would indicate that cells are able to absorb it. Compounds that are intermediate in their metabolism are generated, and they bind to DNA and block protein synthesis, both of which lead to the death of cells. It's possible that the creation of free radicals is responsible for the antimicrobial effect. In cases of invasive amebiasis, the use of metronidazole is recommended.
Tinidazole is a 5-nitroimidazole derivative that is used as a treatment for infections caused by susceptible protozoa. It is unknown how it exerts its anti-Giardia and anti-Entamoeba effects on different types of Entamoeba. Tinidazole is prescribed for the treatment of intestinal amebiasis and amebic liver abscess in patients aged 3 years and older, including adults. These conditions are caused by the bacteria E histolytica.